The Munich techbio company is developing a live bacterial product designed to enhance immune checkpoint inhibitor response in advanced melanoma, with a Phase 1B study planned for 2027 mbiomics GmbH, a Munich-based techbio company developing microbiome-based therapeutics, has completed the third and final closing of its Series A funding round, bringing the total raised to […]<br /> This story continues at The Next Web [...]
The Food and Drug Administration has approved a new device called the Teal Wand, which its creator describes as an "at-home vaginal sample self-collection device for cervical cancer screening.&qu [...]
Today, Copenhagen-based healthcare AI Corti is launching Symphony for Speech-to-Text, a new generation of clinical-grade speech recognition models engineered specifically for real-time dictation, conv [...]
Isomorphic Labs, the AI drug research company led by DeepMind co-founder Demis Hassabis, has closed a $2.1 billion Series B round led by Thrive Capital. The funding will go toward expanding its in-hou [...]
Modern medicine is a marvel, with previously unimaginable cures and treatments now widely available. Think of advanced medical devices such as implantable defibrillators that help regulate heart rhyth [...]
The Stockholm company has spent six years building infrastructure that ensures enterprise data is actually fit for AI, and it has just secured $30M to make that case globally. The pattern is familiar [...]
The FDA is launching a pilot program to monitor clinical trials in real time using AI and cloud computing, a move the agency says could dramatically shorten the time it takes to approve new drugs.< [...]
The weeklong speedrunning marathon Awesome Games Done Quick 2025 wrapped up in the wee hours of Sunday morning, and organizers say it managed to pull in a total of $2,556,305 for Prevent Cancer Founda [...]